Nanosphere (NSPH) Gets CE IVD Mark for Gram-Positive BC-GP on Verigene
Tweet
Share
E-mailGet Alerts NSPH Hot Sheet
Join SI Premium – FREE
Nanosphere, Inc. (Nasdaq: NSPH), has obtained CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on the automated sample-to-result Verigene System.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
- BIGG Digital Assets to rename as Surge Digital, consolidate shares
- Nu Skin EVP of global sales takes medical leave
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
